Current vaccines induce broadly cross-reactive cellular immunity against SARS-CoV-2 variants, including Omicron, and provide protection against severe disease despite a substantially reduced neutralizing antibody response.
- Jinyan Liu
- Abishek Chandrashekar
- Dan H. Barouch